EPO and chronic kidney disease: According to the CDC, the United States has more than 37 million American adults with CKD, with more than one out of every seven people suffering from anemia due to CKD.The currently available treatment option for anemia due to CKD is erythropoietin-stimulating agents (ESA) and iron supplementation [4].